WuXi TIDES: difference between revisions
Diff·revision 10 → 11·06:22, 21 Oct 2024
Difference between revision 10 and revision 11 of WuXi TIDES. 12 lines changed; the page grew by 1,329 bytes.
| Revision 10 — 20:52, 9 Oct 2024 CPeptidePaddy (talk) rm the adjective — an organisation article describes, it does not praise 4,593 bytes +159 | Revision 11 — 06:22, 21 Oct 2024 eGFR_Esme (talk) rm the price; supplier articles carry no price per PP:VN 5,922 bytes +1,329 | ||
|---|---|---|---|
| 27 | The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report. | 27 | The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report. |
| 28 | 28 | ||
| + | 29 | == Operations and documentation practice == | |
| + | 30 | Documentation practice is the most consistently described aspect of the organisation in reports reaching this wiki: shipments are reported to arrive with a batch-specific [[Certificate of analysis|certificate]] naming a [[Batch number|lot]], and the lot identifier on the certificate has matched the vial label throughout the submitted material.{{r|reports}} That correspondence is the condition every other document depends on, and it is recorded here because it is the one thing a purchaser can verify on arrival without instrumentation. | |
| + | 31 | ||
| + | 32 | == Product range == | |
| + | 33 | | Class | Representative listings | Documentation reported | | |
| + | 34 | |---|---|---| | |
| + | 35 | | Incretin analogues | Semaglutide, tirzepatide, retatrutide | Batch certificate with HPLC trace | | |
| + | 36 | | Research peptides | BPC-157, TB-500, growth-hormone secretagogues | Batch certificate | | |
| + | 37 | | Oligonucleotides | Custom synthesis, antisense constructs | Certificate, sequence confirmation | | |
| + | 38 | | SARMs and raw materials | Bulk powders | Certificate with purity; specification sheet on request | | |
| + | 39 | ||
| 29 | == References == | 40 | == References == |
| 30 | {{reflist}} | 41 | {{reflist}} |
| 31 | <ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref> | 42 | <ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref> |
| 32 | <ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref> | 43 | <ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref> |
| + | 44 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> | |
| 33 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | 45 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> |
| 34 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 46 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |